Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Eidos Therapeutics Inc

(NASDAQ: EIDX)
Add to Portfolio
+0.06 (+0.17%)
as of Oct 17, 2019

Last 35.48
Change +0.06 (+0.17%)
Open 35.65
Prev. Close 35.42
Today's Range
34.95
36.30
52wk Range
9.14
49.72
Volume 242,300
Avg Volume 180,480
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
EIDX +0.17% +11.99% +283.98%
DJIA +0.09% +3.92% +5.13%
S&P 500 +0.28% +3.95% +6.72%

Key Statistics

Annual EPS -1.27
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 1,336,310
Weighted Alpha +190.61
Standard Deviation +0.05
Profit Margin N/A
Beta -1.05

Growth Rates

YTD +157.85%
1-Year +273.08%

Opinion

Sell Hold Buy

Recent Headlines

BridgeBio Pharma Terminates Merger Process With Its

BusinessWire via COMTEX - Mon Oct 14, 07:30AM EDT
BridgeBio Pharma, Inc. (NASDAQ: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, announced today that it was unable to come to an agreement with the Special Committee formed by its subsidiary Eidos Th(full story)
BBIO: 18.51 (+0.55), EIDX: 35.48 (+0.06)

Alexion (ALXN) Collaborates With Stealth

ZACKS - Fri Oct 11, 09:27AM EDT
Alexion (ALXN) teams up with Stealth BioTherapeutics for a late-stage therapy for mitochondrial diseases.(full story)
AMGN: 203.56 (+0.35), ALXN: 99.99 (+0.48), EIDX: 35.48 (+0.06), MITO: 6.38 (-0.08)

Eidos Therapeutics to Present Interim Analysis of the

GlobeNewswire via COMTEX - Mon Sep 30, 07:00AM EDT
Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in transthyretin (TTR) amyloidosis (ATTR), today announced that an interim analysis (full story)
EIDX: 35.48 (+0.06)

Eidos Therapeutics to Present at the 2019 Cantor

GlobeNewswire via COMTEX - Thu Sep 19, 08:00AM EDT
Eidos Therapeutics, Inc. (Eidos) (Nasdaq: EIDX) today announced that management will present at the 2019 Cantor Global Healthcare Conference on Thursday, October 3 at 3:00 p.m. EDT in New York, NY.(full story)
EIDX: 35.48 (+0.06)

Alexion (ALXN) Down on News of CFO Clancy's Departure

ZACKS - Thu Sep 19, 07:17AM EDT
Alexion's (ALXN) shares decline, following the news of the departure of its current chief financial officer, Paul Clancy.(full story)
BIIB: 225.60 (-2.12), ALXN: 99.99 (+0.48), AMGN: 203.56 (+0.35), EIDX: 35.48 (+0.06)